India Community Acquired Pneumonia Drugs Market - Industry Trends and Forecast to 2031
India community acquired pneumonia drugs market is expected to reach USD 162.51 million by 2031, from 92.72 million in 2023 growing at the CAGR of 7.5% in the forecast period of 2024 to 2031.
Market Segmentation
India Community Acquired Pneumonia Drugs Market, By Product (Macrolides, B-Lactam Antibiotics, Quinolones, Tetracycline, Carbapenem, Glycopeptide Antibiotics, Pleuromutilin, and Others), Route of Administration (Oral and Intravenous), Dosage (Tablet and Solution), Product Type (Generics and Branded), Mode of Purchase (Prescription and OTC), Type (Bacterial, Virus, and Fungi), Population Type (Children, Geriatrics, and Adults), End User (Hospitals, Specialty Clinics, Homecare, and Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, and Others), Country (India) - Industry Trends and Forecast to 2031
Overview of India Community Acquired Pneumonia Drugs Market Dynamics
Driver
• Rising prevalence and burden of pneumonia
Restraint
• Affordability and price sensitivity associated with the drugs
Opportunity
• Technology driven solutions and innovation
Market Players
Some of the key market players operating in the India community acquired pneumonia drugs market are listed below:
• Pfizer Inc.
• Cipla Inc.
• AstraZeneca
• Abbott
• Teva Pharmaceutical Industries Ltd.
• Novartis AG
• FRESENIUS KABI
• Baxter
• Aurobindo Pharma USA
- 1 Introduction
- 1.1 Objectives Of The Study
- 1.2 Market Definition
- 1.3 Overview Of The India Community Acquired Pneumonia Drugs Market
- 1.4 Currency And Pricing
- 1.5 Limitations
- 1.6 Markets Covered
- 2 Market Segmentation
- 2.1 Markets Covered
- 2.2 Geographical Scope
- 2.3 Years Considered For The Study
- 2.4 Dbmr Tripod Data Validation Model
- 2.5 Primary Interviews With Key Opinion Leaders
- 2.6 Multivariate Modelling
- 2.7 Product Segment Lifeline Curve
- 2.8 Market End User Coverage Grid
- 2.9 Dbmr Market Position Grid
- 2.10 Vendor Share Analysis
- 2.11 Secondary Sources
- 2.12 Assumptions
- 3 Executive Summary
- 4 Premium Insights
- 4.1 Pestal Analysis
- 4.2 Porters Five Forces
- 5 Regulations
- 6 Market Overview
- 6.1 Drivers
- 6.1.1 Rising Prevalence Of Pneumonia
- 6.1.2 Growing Antibiotic Resistance Pathogens Drugs
- 6.1.3 Increasing Healthcare Awareness And Expenditure
- 6.1.4 Growing Demand For Generic And Locally Produced Drugs
- 6.2 Restraints
- 6.2.1 Affordability And Price Sensitivity Associated With The Drugs
- 6.2.2 Unequal Distribution Of Healthcare Resources In Different Locality
- 6.2.3 Pipeline Of New Antibiotic Development
- 6.3 Oppurtunities
- 6.3.1 Technology-driven Solutions And Innovation
- 6.3.2 Focus On Affordability And Generics Of The Pneumonia Drugs
- 6.3.3 Focus On Leveraging Telemedicine And Specific Aged Patient
- 6.4 Challenges
- 6.4.1 Limited Healthcare Infrastructure And Access
- 6.4.2 Antibiotic Resistance And Counterfeiting In Pharmaceutical Drugs
- 7 India Community Acquired Pneumonia Drugs Market, By Product
- 7.1 Overview
- 7.2 Macrolides
- 7.2.1 Azithromycin
- 7.2.2 Erythromycin
- 7.2.3 Clarithromycin
- 7.2.4 Others
- 7.3 B-lactam Antibiotics
- 7.3.1 Cephalosporin
- 7.3.1.1 Third Generation Cephalosporin
- 7.3.1.2 Second Generation Cephalosporin
- 7.3.1.3 Fourth Generation Cephalosporin
- 7.3.1.4 First Generation Cephalosporin
- 7.3.2 Amoxicillin And Clavulanate Potassium
- 7.3.3 Piperacillin And Tazobactam
- 7.3.4 Ampicillin And Sulbactam
- 7.3.5 Others
- 7.4 Quinolones
- 7.4.1 Moxifloxacin
- 7.4.2 Levofloxacin
- 7.4.3 Gemifloxacin
- 7.4.4 Gatifloxacin
- 7.4.5 Ciprofloxacin
- 7.4.6 Delafloxacin
- 7.4.7 Others
- 7.5 Tetracycline
- 7.5.1 Doxycycline
- 7.5.2 Omadacycline
- 7.5.3 Others
- 7.6 Carbapenem
- 7.6.1 Imipenem
- 7.6.2 Meropenem
- 7.6.3 Ertapenem
- 7.7 Glycopeptide Antibiotics
- 7.7.1 Vancomycin
- 7.7.2 Teicoplanin
- 7.7.3 Others
- 7.8 Pleuromutilin
- 7.9 Others
- 8 India Community Acquired Pneumonia Drugs Market, By Route Of Administration
- 8.1 Overview
- 8.2 Oral
- 8.3 Intravenous
- 9 India Community Acquired Pneumonia Drugs Market, By Dosage
- 9.1 Overview
- 9.2 Tablet
- 9.3 Solution
- 10 India Community Acquired Pneumonia Drugs Market, By Product Type
- 10.1 Overview
- 10.2 Generics
- 10.3 Branded
- 11 India Community Acquired Pneumonia Drugs Market, By Mode Of Purchase
- 11.1 Overview
- 11.2 Prescription
- 11.3 Otc
- 12 India Community Acquired Pneumonia Drugs Market, By Type
- 12.1 Overview
- 12.2 Bacterial
- 12.3 Virus
- 12.4 Fungi
- 13 India Community Acquired Pneumonia Drugs Market, By Population Type
- 13.1 Overview
- 13.2 Children
- 13.3 Geriatrics
- 13.4 Adults
- 14 India Community Acquired Pneumonia Drugs Market, By End User
- 14.1 Overview
- 14.2 Hospitals
- 14.3 Specialty Clinics
- 14.4 Home Care
- 14.5 Others
- 15 India Community Acquired Pneumonia Drugs Market, By Distribution Channel
- 15.1 Overview
- 15.2 Hospital Pharmacy
- 15.3 Retail Pharmacy
- 15.4 Online Pharmacy
- 15.5 Others
- 16 India Community Acquired Pneumonia Drugs Market, Company Landscape
- 16.1 Company Share Analysis: India
- 17 Swot Analysis
- 18 Company Profiles
- 18.1 Pfizer Inc.
- 18.1.1 Company Snapshot
- 18.1.2 Revenue Analysis
- 18.1.3 Product Portfolio
- 18.1.4 Recent Development
- 18.2 Cipla Inc.
- 18.2.1 Company Snapshot
- 18.2.2 Revenue Analysis
- 18.2.3 Product Portfolio
- 18.2.4 Recent Development
- 18.3 Astrazeneca
- 18.3.1 Company Snapshot
- 18.3.2 Revenue Analysis
- 18.3.3 Product Portfolio
- 18.3.4 Recent Development
- 18.4 Abbott
- 18.4.1 Company Snapshot
- 18.4.2 Revenue Analysis
- 18.4.3 Product Portfolio
- 18.4.4 Recent Development
- 18.5 Teva Pharmaceutical Industries Ltd.
- 18.5.1 Company Snapshot
- 18.5.2 Revenue Analysis
- 18.5.3 Product Portfolio
- 18.5.4 Recent Developments
- 18.6 Aurobindo Pharma Usa
- 18.6.1 Company Snapshot
- 18.6.2 Revenue Analysis
- 18.6.3 Product Portfolio
- 18.6.4 Recent Development
- 18.7 Baxter
- 18.7.1 Company Snapshot
- 18.7.2 Revenue Analysis
- 18.7.3 Product Portfolio
- 18.7.4 Recent Development
- 18.8 Fresenius Kabi
- 18.8.1 Company Snapshot
- 18.8.2 Revenue Analysis
- 18.8.3 Product Portfolio
- 18.8.4 Recent Development
- 18.9 Novartis Ag
- 18.9.1 Company Snapshot
- 18.9.2 Revenue Analysis
- 18.9.3 Product Portfolio
- 18.9.4 Recent Development
- 19 Questionnaire
- 20 Related Reports
- List Of Tables
- Table 1 India Community Acquired Pneumonia Drugs Market, By Product, 2022-2031 (Usd Million)
- Table 2 India Macrolides In Community Acquired Pneumonia Drugs Market, By Type, 2022-2031 (Usd Million)
- Table 3 India B-lactam Antibiotics In Community Acquired Pneumonia Drugs Market, By Type, 2022-2031 (Usd Million)
- Table 4 India Cephalosporin In Community Acquired Pneumonia Drugs Market, By Type, 2022-2031 (Usd Million)
- Table 5 India Quinolones In Community Acquired Pneumonia Drugs Market, By Type, 2022-2031 (Usd Million)
- Table 6 India Tetracycline In Community Acquired Pneumonia Drugs Market, By Type, 2022-2031 (Usd Million)
- Table 7 India Carbapenem In Community Acquired Pneumonia Drugs Market, By Type, 2022-2031 (Usd Million)
- Table 8 India Glycopeptide Antibiotics In Community Acquired Pneumonia Drugs Market, By Type, 2022-2031 (Usd Million)
- Table 9 India Community Acquired Pneumonia Drugs Market, By Route Of Administration, 2022-2031 (Usd Million)
- Table 10 India Community Acquired Pneumonia Drugs Market, By Dosage, 2022-2031 (Usd Million)
- Table 11 India Community Acquired Pneumonia Drugs Market, By Product Type, 2022-2031 (Usd Million)
- Table 12 India Community Acquired Pneumonia Drugs Market, By Mode Of Purchase 2022-2031 (Usd Million)
- Table 13 India Community Acquired Pneumonia Drugs Market, By Type, 2022-2031 (Usd Million)
- Table 14 India Community Acquired Pneumonia Drugs Market, By Population Type, 2022-2031 (Usd Million)
- Table 15 India Community Acquired Pneumonia Drugs Market, By End User, 2022-2031 (Usd Million)
- Table 16 India Community Acquired Pneumonia Drugs Market, By Distribution Channel, 2022-2031 (Usd Million)
- List Of Figures
- Figure 1 India Community Acquired Pneumonia Drugs Market: Segmentation
- Figure 2 India Community Acquired Pneumonia Drugs Market: Data Triangulation
- Figure 3 India Community Acquired Pneumonia Drugs Market: Droc Analysis
- Figure 4 India Community Acquired Pneumonia Drugs Market: Countrywise Market Analysis
- Figure 5 India Community Acquired Pneumonia Drugs Market: Company Research Analysis
- Figure 6 India Community Acquired Pneumonia Drugs Market: Interview Demographics
- Figure 7 India Community Acquired Pneumonia Drugs Market: Market End User Coverage Grid
- Figure 8 India Community Acquired Pneumonia Drugs Market: Dbmr Market Position Grid
- Figure 9 India Community Acquired Pneumonia Drugs Market: Vendor Share Analysis
- Figure 10 India Community Acquired Pneumonia Drugs Market: Segmentation
- Figure 11 Rising Prevalence Of Pneumonia Is Driving The Growth Of The India Community Acquired Pneumonia Drugs Market From 2024 To 2034
- Figure 12 Macrolides Segment Is Expected To Account For The Largest Share Of The India Community Acquired Pneumonia Drugs Market In 2024 To 2031
- Figure 13 Drivers, Restraints, Opportunities, And Challenges Of Global Rapid Diagnostic Tests (Rtd) Market
- Figure 14 India Community Acquired Pneumonia Drugs Market: By Product, 2023
- Figure 15 India Community Acquired Pneumonia Drugs Market: By Product, 2024-2031 (Usd Million)
- Figure 16 India Community Acquired Pneumonia Drugs Market: By Product, Cagr (2024-2031)
- Figure 17 India Community Acquired Pneumonia Drugs Market: By Product, Lifeline Curve
- Figure 18 India Community Acquired Pneumonia Drugs Market: By Route Of Administration, 2023
- Figure 19 India Community Acquired Pneumonia Drugs Market: By Route Of Administration, 2024-2031 (Usd Million)
- Figure 20 India Community Acquired Pneumonia Drugs Market: By Route Of Administration, Cagr (2024-2031)
- Figure 21 India Community Acquired Pneumonia Drugs Market: By Route Of Administration, Lifeline Curve
- Figure 22 India Community Acquired Pneumonia Drugs Market: By Dosage, 2023
- Figure 23 India Community Acquired Pneumonia Drugs Market: By Dosage, 2024-2031 (Usd Million)
- Figure 24 India Community Acquired Pneumonia Drugs Market: By Dosage, Cagr (2024-2031)
- Figure 25 India Community Acquired Pneumonia Drugs Market: By Dosage, Lifeline Curve
- Figure 26 India Community Acquired Pneumonia Drugs Market: By Product Type, 2023
- Figure 27 India Community Acquired Pneumonia Drugs Market: By Product Type, 2024-2031 (Usd Million)
- Figure 28 India Community Acquired Pneumonia Drugs Market: By Product Type, Cagr (2024-2031)
- Figure 29 India Community Acquired Pneumonia Drugs Market: By Product Type, Lifeline Curve
- Figure 30 India Community Acquired Pneumonia Drugs Market: By Mode Of Purchase, 2023
- Figure 31 India Community Acquired Pneumonia Drugs Market: By Mode Of Purchase, 2024-2031 (Usd Million)
- Figure 32 India Community Acquired Pneumonia Drugs Market: By Mode Of Purchase, Cagr (2024-2031)
- Figure 33 India Community Acquired Pneumonia Drugs Market: By Mode Of Purchase, Lifeline Curve
- Figure 34 India Community Acquired Pneumonia Drugs Market: By Type, 2023
- Figure 35 India Community Acquired Pneumonia Drugs Market: By Type, 2024-2031 (Usd Million)
- Figure 36 India Community Acquired Pneumonia Drugs Market: By Type, Cagr (2024-2031)
- Figure 37 India Community Acquired Pneumonia Drugs Market: By Type, Lifeline Curve
- Figure 38 India Community Acquired Pneumonia Drugs Market: By Population Type, 2023
- Figure 39 India Community Acquired Pneumonia Drugs Market: By Population Type, 2024-2031 (Usd Million)
- Figure 40 India Community Acquired Pneumonia Drugs Market: By Population Type, Cagr (2024-2031)
- Figure 41 India Community Acquired Pneumonia Drugs Market: By Population Type, Lifeline Curve
- Figure 42 India Community Acquired Pneumonia Drugs Market: By End User, 2023
- Figure 43 India Community Acquired Pneumonia Drugs Market: By End User, 2024-2031 (Usd Million)
- Figure 44 India Community Acquired Pneumonia Drugs Market: By End User, Cagr (2024-2031)
- Figure 45 India Community Acquired Pneumonia Drugs Market: By End User, Lifeline Curve
- Figure 46 India Community Acquired Pneumonia Drugs Market: By Distribution Channel, 2023
- Figure 47 India Community Acquired Pneumonia Drugs Market: By Distribution Channel, 2024-2031 (Usd Million)
- Figure 48 India Community Acquired Pneumonia Drugs Market: By Distribution Channel, Cagr (2024-2031)
- Figure 49 India Community Acquired Pneumonia Drugs Market: By Distribution Channel, Lifeline Curve
- Figure 50 India Community Acquired Pneumonia Drugs Market: Company Share 2023 (%)
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook